Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 32 publications
0
2
0
Order By: Relevance
“…It is worth emphasizing that the levels of CEA may be used to differentiate between mucinous and non-mucinous lesions [ 55 ]. CEA level of >192 μg/L is the cut-off value for the cyst differentiation with the sensitivity and specificity of 52–78% and 63–91%, respectively [ 56 , 57 ]. In turn, the concentration of amylase is usually normal, however a high level does not exclude MCN [ 31 ].…”
Section: Types Of Incidental Pancreatic Lesionsmentioning
confidence: 99%
“…It is worth emphasizing that the levels of CEA may be used to differentiate between mucinous and non-mucinous lesions [ 55 ]. CEA level of >192 μg/L is the cut-off value for the cyst differentiation with the sensitivity and specificity of 52–78% and 63–91%, respectively [ 56 , 57 ]. In turn, the concentration of amylase is usually normal, however a high level does not exclude MCN [ 31 ].…”
Section: Types Of Incidental Pancreatic Lesionsmentioning
confidence: 99%
“…Biomarker analysis of fine needle aspirate (FNA) fluid collected from pancreatic cysts offers great potential for high accuracy diagnosis of mucinous cysts. The FNA biomarker used most commonly in current clinical assessments is carcinoembryonic antigen (CEA) immunoassay, which has a reported pooled diagnostic sensitivity of 60.4% (95% CI 57.7–62.9) and specificity of 88.6% (95% CI 85.9–90.9) using a 192 ng/mL cutoff level [ 20 ]. With room for diagnostic improvement, other biomarkers have also been studied for this purpose.…”
Section: Introductionmentioning
confidence: 99%